South Texas Dermatopathology and Laboratory of Dermatopathology ADX Notify Their Patients of AMCA Breach (Update4)

Update 1: And now add Seacoast Pathology, (9,300 affected) to the 20,000 described in the original post below, and the approximately 21 million disclosed last month.

Update 2 (July 21): And now add American Esoteric Laboratories (541,900), CBLPath, Inc. (148,900), and Natera (unspecified number) to the list and tally.

Update 3 (July 22): And now add Arizona Dermatopathology (7,000) and Austin Pathology Associates (46,500) to the list and tally.

Update 4 (July 23): And also Laboratory Medicine Consultants, Ltd. (147600), Pathology Solutions (13,300), Western Pathology Consultants (4550) to the list and tally.


Original post:

Add South Texas Dermatopathology, PLLC and Laboratory of Dermatopathology ADX, LLC (“LDA”), to the list of victims of the American Medical Collection Agency breach. Here are their press releases 


SAN ANTONIO, July 19, 2019 /PRNewswire/ — South Texas Dermatopathology, PLLC has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency (“AMCA”) of a data security incident involving the AMCA payment website. AMCA is an independent collection agency that South Texas Dermatopathology and many other entities used for debt collection.  The incident is limited to AMCA’s systems.  The security of South Texas Dermatopathology’s systems was not affected by this incident.

According to AMCA, on March 21, 2019, AMCA became aware of facts indicating there had been a data security incident. After conducting an investigation, in May of 2019, AMCA notified South Texas Dermatopathology about the incident and informed South Texas Dermatopathology that an AMCA database containing information for some South Texas Dermatopathology patients had been affected.  However, at the time of AMCA’s initial notification, AMCA did not provide South Texas Dermatopathology with enough information for South Texas Dermatopathology to identify potentially affected patients or confirm the nature of patient information potentially involved in the incident, and South Texas Dermatopathology’s investigation is on-going. Based on the information provided by AMCA, the following information belonging to South Texas Dermatopathology patients may have been affected by the incident: patient names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information.  AMCA has advised South Texas Dermatopathology that its patient’s social security numbers were not involved in the incident.  South Texas Dermatopathology does not provide AMCA healthcare records such as laboratory results and clinical history.

In response to the breach, AMCA sent notification letters to approximately 1,200 South Texas Dermatopathology patients informing them that their names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information may have been impacted. In addition, based on the investigation and the information provided by AMCA, South Texas Dermatopathology estimates that approximately another 14,900 patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information impacted by this incident.  For these patients, credit card and banking information is not affected. The impact of this incident is limited to laboratory services provided to patients in the United States whose accounts were referred for debt collection.

Individuals with questions about this incident or questions about precautionary steps they can take may call 833-300-6928 for additional information.

South Texas Dermatopathology takes the security of its patients’ information very seriously, including the security of data handled by vendors.  As a result of the investigation, South Texas Dermatopathology is no longer using AMCA for collection efforts.

The privacy and protection of patient information is a top priority.  South Texas Dermatopathology greatly appreciates the patience and loyalty of its patients as it works to respond to this incident.


WOODBURY, N.Y., July 19, 2019 /PRNewswire/ — Laboratory of Dermatopathology ADX, LLC (“LDA”), has been informed by Retrieval Masters Creditors Bureau d/b/a American Medical Collection Agency (“AMCA”) of a data security incident involving the AMCA payment website.  AMCA is an independent collection agency that LDA and many other entities used for debt collection.  The incident is limited to AMCA’s systems.  The security of LDA’s systems was not affected by this incident.

According to AMCA, on March 21, 2019, AMCA became aware of facts indicating there had been a data security incident. After conducting an investigation, in May of 2019, AMCA notified LDA about the incident and informed LDA that an AMCA database containing information for some LDA patients had been affected.  However, at the time of AMCA’s initial notification, AMCA did not provide LDA with enough information for LDA to identify potentially affected patients or confirm the nature of patient information potentially involved in the incident, and LDA’s investigation is on-going. Based on the information provided by AMCA, the following information belonging to LDA patients may have been affected by the incident: patient names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information.  AMCA has advised LDA that its patient’s social security numbers were not involved in the incident.  LDA does not provide AMCA healthcare records such as laboratory results and clinical history.

In response to the breach, AMCA sent notification letters to approximately 240 LDA patients informing them that their names, addresses, phone numbers, dates of birth, dates of service, balance information, credit card or banking information and treatment provider information may have been impacted.  In addition, based on the investigation and the information provided by AMCA, LDA estimates that approximately another 4,000 patients may have had their names, addresses, phone numbers, dates of birth, dates of service, balance information and treatment provider information impacted by this incident.  For these patients, credit card and banking information is not affected. The impact of this incident is limited to laboratory services provided to patients in the United States whose accounts were referred for debt collection.

Individuals with questions about this incident or questions about precautionary steps they can take may call 833-300-6928 for additional information.

Laboratory of Dermatopathology ADX, LLC takes the security of its patients’ information very seriously, including the security of data handled by vendors.  As a result of the investigation, LDA is no longer using AMCA for collection efforts.

The privacy and protection of patient information is a top priority.  LDA greatly appreciates the patience and loyalty of its patients as it works to respond

About the author: Dissent